<DOC>
	<DOCNO>NCT01756937</DOCNO>
	<brief_summary>Efficacy safety Imotun capsule osteoarthritis knee</brief_summary>
	<brief_title>Efficacy Safety Imotun Capsule Osteoarthritis Knee</brief_title>
	<detailed_description>A six-month , multi center , randomizied , double blind , parallel-group , placebo control study evaluate efficacy safety Imotun capsule osteoarthritis knee</detailed_description>
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Osteoarthritis , Knee</mesh_term>
	<criteria>Agreement write informed consent 40 year age old Patients 63months history OA knee accord ACR criterion Radiographic evidence Kellgren &amp; Lawrence grade II III OA knee The 100mm Pain VAS 40mm The Lequensne 's index 5 Treatment SYSADOA within 3 month History joint surgery within 5 year Arthroscopic surgery within 1year Intraarticular injection within 3 month Treatment NASIDs within 7 day Any history adverse reaction study drug clinically significant hepatic , renal , cardiovascular disease Patients gastrointestinal ulcer bleed disorder Pregnant woman , nurse mother Fertile woman practice contraception appropriate method History drug abuse alcoholism Patients clinical trial experimental treatment past 4 week An impossible one participate clinical trial investigator 's decision</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>osteoarthritis knee</keyword>
</DOC>